相似文献
1
Epigenetic modifications in human thyroid cancer.人类甲状腺癌中的表观遗传修饰。
Biomed Rep. 2015 Jan;3(1):3-8. doi: 10.3892/br.2014.375. Epub 2014 Nov 3.
2
Potential of epigenetic events in human thyroid cancer.表观遗传事件在人类甲状腺癌中的潜在作用。
Cancer Genet. 2019 Nov;239:13-21. doi: 10.1016/j.cancergen.2019.08.006. Epub 2019 Aug 23.
3
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.RET、BRAF和RAS癌基因的经典点突变在同一腺体中同时发生的甲状腺乳头状癌和甲状腺髓样癌中并不相同。
J Endocrinol Invest. 2017 Jan;40(1):55-62. doi: 10.1007/s40618-016-0526-5. Epub 2016 Aug 17.
4
Molecular pathology of differentiated thyroid cancer.分化型甲状腺癌的分子病理学
Q J Nucl Med Mol Imaging. 2009 Oct;53(5):440-53.
5
MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5.微小RNA let7在甲状腺癌中的表达：与其指定靶标HMGA2和SLC5A5的相关性
J Cancer Res Clin Oncol. 2016 Jun;142(6):1213-20. doi: 10.1007/s00432-016-2138-z. Epub 2016 Mar 9.
6
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.有证据表明，一部分间变性甲状腺癌是由于BRAF和p53突变而由乳头状癌演变而来。
Cancer. 2005 Jun 1;103(11):2261-8. doi: 10.1002/cncr.21073.
7
The role of epigenetic alterations in papillary thyroid carcinogenesis.表观遗传改变在甲状腺乳头状癌发生中的作用。
J Thyroid Res. 2011;2011:895470. doi: 10.4061/2011/895470. Epub 2011 Jun 14.
8
Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.在滤泡状甲状腺癌和间变性甲状腺癌中存在7号染色体长臂杂合性缺失，但在乳头状甲状腺癌中不存在。
J Clin Endocrinol Metab. 1999 Sep;84(9):3235-40. doi: 10.1210/jcem.84.9.5986.
9
Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.甲状腺癌中RASSF1A基因CpG岛启动子频繁发生表观遗传沉默。
Cancer Res. 2002 Jul 1;62(13):3698-701.
10
Expression of MicroRNAs in Thyroid Carcinoma.微小RNA在甲状腺癌中的表达
Methods Mol Biol. 2017;1617:261-280. doi: 10.1007/978-1-4939-7046-9_19.
引用本文的文献
1
Landscape of TET2 Mutations: From Hematological Malignancies to Solid Tumors.TET2突变图谱：从血液系统恶性肿瘤到实体瘤
Cancer Med. 2025 Mar;14(6):e70792. doi: 10.1002/cam4.70792.
2
The role of genetic and epigenetic modifications as potential biomarkers in the diagnosis and prognosis of thyroid cancer.基因和表观遗传修饰作为甲状腺癌诊断和预后潜在生物标志物的作用。
Front Oncol. 2024 Nov 4;14:1474267. doi: 10.3389/fonc.2024.1474267. eCollection 2024.
3
Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity.达沙替尼和曲美替尼促进抗肿瘤代谢活性。
Cells. 2023 May 12;12(10):1374. doi: 10.3390/cells12101374.
4
MicroRNA‑153 may act as a potential biomarker and prognostic indicator of patients with gastric cancer.微小RNA-153可能作为胃癌患者的潜在生物标志物和预后指标。
Oncol Lett. 2023 May 12;26(1):278. doi: 10.3892/ol.2023.13864. eCollection 2023 Jul.
5
Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers.甲状腺球蛋白测量不可靠患者的甲状腺癌持续存在：循环微小RNA作为候选替代生物标志物
Cancers (Basel). 2022 Nov 16;14(22):5620. doi: 10.3390/cancers14225620.
6
Induction of the BRAFV600E Mutation in Thyroid Cells Leads to Frequent Hypermethylation.甲状腺细胞中BRAFV600E突变的诱导导致频繁的高甲基化。
Clin Exp Otorhinolaryngol. 2022 Aug;15(3):273-282. doi: 10.21053/ceo.2022.00206. Epub 2022 May 4.
7
Comparing Oxidative Stress Status Among Iranian Males and Females with Malignant and Non-malignant Thyroid Nodules.比较患有恶性和非恶性甲状腺结节的伊朗男性和女性的氧化应激状态。
Int J Endocrinol Metab. 2021 Jan 26;19(1):e105669. doi: 10.5812/ijem.105669. eCollection 2021 Jan.
8
Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma.人甲状腺乳头状癌中四个抑癌基因的启动子甲基化
Iran J Pathol. 2019 Fall;14(4):290-298. doi: 10.30699/ijp.2019.94401.1922. Epub 2019 Sep 22.
9
Prognostic factors in thyroid carcinomas: a 17-year outcome study.甲状腺癌的预后因素：一项为期17年的结局研究。
Arch Endocrinol Metab. 2020 Feb;64(1):30-37. doi: 10.20945/2359-3997000000175. Epub 2019 Sep 30.
10
Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer.系统生物学方法研究遗传和表观遗传分子进展机制，以鉴定甲状腺乳头状癌中的基因表达特征。
Int J Mol Sci. 2019 May 23;20(10):2536. doi: 10.3390/ijms20102536.
本文引用的文献
1
Epigenetic reprogramming in breast cancer: from new targets to new therapies.乳腺癌中的表观遗传重编程：从新靶点到新疗法。
Ann Med. 2014 Sep;46(6):397-408. doi: 10.3109/07853890.2014.923740. Epub 2014 Jul 24.
2
Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer.结直肠癌中新型高甲基化基因的鉴定及长春新碱的去甲基化作用
J Exp Clin Cancer Res. 2014 Jan 6;33(1):4. doi: 10.1186/1756-9966-33-4.
3
miR-127 regulates cell proliferation and senescence by targeting BCL6.miR-127 通过靶向 BCL6 调节细胞增殖和衰老。
PLoS One. 2013 Nov 25;8(11):e80266. doi: 10.1371/journal.pone.0080266. eCollection 2013.
4
Analysis of loss of heterozygsity effect on thyroid tumor with oxyphilia cell locus in familial non medullary thyroid carcinoma in Iranian families.伊朗家族性非髓样甲状腺癌中嗜酸性细胞位点杂合性缺失对甲状腺肿瘤影响的分析
Indian J Hum Genet. 2012 Sep;18(3):340-3. doi: 10.4103/0971-6866.107989.
5
Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.在中国患者中，甲状腺乳头状癌中 miRNA 的表达与 BRAF 突变及临床病理特征相关。
Int J Endocrinol. 2013;2013:128735. doi: 10.1155/2013/128735. Epub 2013 Apr 11.
6
Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma.在甲状腺髓样癌中，miR-10a 和 miR-375 的过表达和 YAP1 的下调。
Exp Mol Pathol. 2013 Aug;95(1):62-7. doi: 10.1016/j.yexmp.2013.05.001. Epub 2013 May 16.
7
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.DNA 甲基化特征可识别生物学上不同的甲状腺癌亚型。
J Clin Endocrinol Metab. 2013 Jul;98(7):2811-21. doi: 10.1210/jc.2012-3566. Epub 2013 May 10.
8
MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.MicroRNA-146a 通过靶向 PRKCE 调节甲状腺乳头状瘤的发展。
Int J Cancer. 2014 Jan 15;134(2):257-67. doi: 10.1002/ijc.28141. Epub 2013 Sep 18.
9
MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome.家族性和散发性髓样甲状腺癌中的 microRNA 谱：与 RET 状态和预后的初步关系。
Thyroid. 2012 Sep;22(9):890-6. doi: 10.1089/thy.2012.0045. Epub 2012 Jun 29.
10
Association between TPO gene polymorphisms and Anti-TPO level in Tehranian population: TLGS.TPO 基因多态性与德黑兰人群 Anti-TPO 水平的相关性：TLGS。
Gene. 2012 Apr 25;498(1):116-9. doi: 10.1016/j.gene.2012.01.077. Epub 2012 Feb 3.
Zotero 插件